That doesn't stop people from trying -- according to Yahoo Finance, FXI (iShares China Large-Cap ETF) was one of the most-traded (by volume) ETFs yesterday.
You should look closely at solar rate plans and interconnection fees in your area. If you're hoping to save money with solar, it's possible that you never recoup the initial investment because of the way the newer rate plans are structured (esp. for PG&E).
In the bay area, it might be cheaper to opt into 100% renewable rate plans from CleanPowerSF or Peninsula Clean Energy. (Silicon Valley Power is 100% renewable by default, IIRC.)
I want to say that I remember seeing this page in high school in the late 00s, although the Internet Archive only seems to go back to 2012 for this exact URL.
VP8 should be required by the base WebRTC spec, but some devices only have hardware acceleration for H.264 so you should test the actual performance before changing codecs. Also consider using VP9 / AV1 if you know all the devices in a call support it and are fast enough to encode/decode it.
Hmm, I wonder if they're doing this so they can drop some code for Spectre/Meltdown mitigations? If memory serves the fix was somewhere around the 10th-11th gen for Intel.
Personally, I'd love to see you optimize for people who start and iterate upon an app from a mobile device and preview/use the app on the same device. Since the messages are just English text, the extra presses to type curly/square braces don't constrain you on mobile. Sometimes I get writer's block at my computer in a way that I don't get on my phone.
In particular, I'd hide/disable the sign-in-with-Google pop-up on phone-size screens (it takes a third of the screen for me), and make sure that CSS/styling makes everything fit on the code and preview screens on a phone, even in mWeb.
My impression is that the "indistinguishable from placebo" is only in reference to a study on people with Sciatica, but that a different study did show a statistically-significant effect on post-surgical pain.
$465 USD for a 15-day supply definitely pricey -- but options for people who weren't well-served by Purdue Pharma / OxyContin seem good, especially if the mechanism of action is different.